| |
The Wall Street Journal’s Patent Scorecard data reflects standard blended quality and
quantity patent metrics. Technology Strength is the ranking indicator for most sectors.
Industries that are more reliant on R&D and the sciences such as Biotechnology and
Pharmaceuticals are ranked by Science Strength. For companies represented in multiple
industry Scorecards, only industry-specific patents within the portfolio are considered
in calculations. In the simplest terms, each company is measured by Quality, Quantity,
Science and Speed.
|
|
|
|
The Wall Street Journal weekly scorecard is broken into three major sections. Following an
industry introduction, the scorecard highlights the current industry leader, lists the top 35
companies ranked by patent portfolio quality,
and provides Dow Jones industry group performance data for the past year.
The top company is mapped against industry averages for the most significant patent metrics,
including innovation cycle time, industry impact, and patent activity. Stock performance comparisons will
include the industry average and several key competitors.
The top 35 companies in the industry are ranked weekly by The Patent Board’s Strength rankings. Fifteen
of the 17 industries are ranked by Technology Strength. Biotechnology and Pharmaceuticals, which are
more closely linked to scientific research and innovation, are ranked by Science Strength.
Dow Jones links patent quality and market performance by providing this familiar view of a company’s
52-week financial achievements. Unless otherwise noted, all closing prices are in U.S. dollars.
|
|
|
|
|
|
Portfolio Metric Definitions
Technology Strength™:
provides an aggregate assessment of patents and innovation by considering the combined quality and
quantity aspects of a company’s portfolio.
Industry Impact™: quantifies
how influential a company’s patent portfolio is on the development of technologies in other
companies, compared to rest of the industry.
Patents Granted:
equals the number of industry-specific U.S. patents granted in a given year,
excluding design and other special-case inventions. Only industry-specific patent
counts are represented for the multi-industry companies.
Science Strength™: measures,
at an aggregate level, the degree to which a company’s patent portfolio is linked to core science.
Research Intensity™: tracks a
company’s level of fundamental research in a given industry compared to other companies, portfolios
and patents across the same technology areas.
Innovation Cycle Time™: indicates
the speed at which a company turns leading-edge technology and core research into patent assets.
Measured in years, a lower number is most desirable.
|
|
